Capricor Therapeutics Announces Pricing of Approximately $75 Million Public Offering of Common Stock
SAN DIEGO, Oct. 17, 2024 ( GLOBE NEWSWIRE ) -- Capricor Therapeutics ( NASDAQ: CAPR ) , a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, today announced the pricing of its underwritten offering of 4,412,000 shares of common ...
| Ticker |
Sentiment |
Impact |
|
META
|
Neutral
|
4 %
|
|
CAPR
|
Neutral
|
12 %
|
|
NPNKF
|
Somewhat Bullish
|
4 %
|
